Lazuriton Nano Biotechnology (U.S.A.) Inc.: cash_and_equivalents
| Value | {"amount": 1197, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "currency": "USD"} |
|---|---|
| Period | (as of 2019-03-31) |
| Status | current |
| Entity | Lazuriton Nano Biotechnology (U.S.A.) Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T17:07:30.346437+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/bb6a6457-6cbe-48c0-86ea-cd5ebc5afe2e
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001640334-19-001401Retrieved: 2026-08-19T17:07:30.346437+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001666178/cash-and-equivalents/2019-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/bb6a6457-6cbe-48c0-86ea-cd5ebc5afe2e
History
- no predecessors — first report